Gregory M. Glenn
2017
In 2017, Gregory M. Glenn earned a total compensation of $1.2M as President, Research and Development at Novavax, a 26% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $229,500 |
|---|---|
| Option Awards | $531,250 |
| Salary | $450,000 |
| Other | $10,500 |
| Total | $1,221,250 |
Glenn received $531.3K in option awards, accounting for 44% of the total pay in 2017.
Glenn also received $229.5K in non-equity incentive plan, $450K in salary and $10.5K in other compensation.
Rankings
In 2017, Gregory M. Glenn's compensation ranked 8,024th out of 14,666 executives tracked by ExecPay. In other words, Glenn earned more than 45.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,024 out of 14,666 | 45th |
Division Manufacturing | 3,017 out of 5,768 | 48th |
Major group Chemicals And Allied Products | 987 out of 2,074 | 52nd |
Industry group Drugs | 771 out of 1,730 | 55th |
Industry Biological Products, Except Diagnostic Substances | 141 out of 316 | 55th |
Source: SEC filing on April 30, 2018.
Glenn's colleagues
We found four more compensation records of executives who worked with Gregory M. Glenn at Novavax in 2017.